The Simplify Health Care ETF, identified by its symbol PINK, is engineered to generate significant long-term capital appreciation. It offers investors diversified exposure to pioneering and innovative companies of varying market capitalizations across crucial healthcare sub-sectors, including biotechnology, medical technology, gene therapy, and other rapidly expanding health-related industries. The fund is expertly managed by Michael Taylor, who serves as the lead portfolio manager, bringing more than two decades of specialized experience in overseeing long/short healthcare equity portfolios for prominent hedge funds. A distinguishing feature of PINK is its status as the first entirely pro bono ETF focused on the healthcare sector. All net profits generated by the fund are pledged for annual donation to the Susan G. Komen foundation, embodying its mission: "PINK: Shares for the Cure." As of September 1, 2025, these charitable contributions have amounted to $350,000.

Eli Lilly and Company

Humana Inc.

Arcutis Biotherapeutics, Inc.

Warby Parker Inc.

Thermo Fisher Scientific Inc.

Johnson & Johnson

AbbVie Inc.

PureCycle Technologies, Inc.

UnitedHealth Group Incorporated

Avantor, Inc.

Healthcare

Consumer Cyclical

Industrials

Cash & Others

Simplify Health Care ETF

PINK Holdings & Sector Breakdown